Depression Flashcards
DSM-5 criteria for MDD
5 symptoms present during the same 2 week period
depressed mood or decreased interest + 4 symptoms from DSIGECAPS
DSIGECAPS
depressed mood
sleep
interest
guilt
energy
concentration
appetite
psychomotor
suicide
onset of MDD
most commonly late 20s but can develop at any age
duration of MDD
median time to recovery is 20 weeks with adequate treatment
__% of patients with a single episode with recover without recurrence
50%
what defines a RESPONSE to treatment
> 50% reduction in symptom severity
what defines REMISSION
absence of depressive symptoms (or only 1-2 mild symptoms) for >2 months
goal of acute phase
remission
select initial agent based on patient factors, optimize regiment
goal of continuation phase
prevent RELAPSE
goal of maintenance phae
prevent RECURRENCE
monoamine hypothesis
depressive symptoms related to deficiencies in 5HT, NE, DA
dysregulation hypothesis
depression results from dysregulation of neurotransmitters that leads to alterations in pre & post receptors
neuroendocrine hypothesis
dysregulation of thyroid & HPA axis results in depression
SSRI mechanism
inhibit reuptake of 5HT in the presynaptic neuron of CNS–> leading to increased serotonin in synaptic cleft
SSRI place in therapy
first line for MDD: well tolerated, low toxicity
SSRI (general) dosing
daily
SSRI drugs
citalopram
escitalopram
sertraline
paroxetine
fluoxetine
fluvoxamine
vortioxetine
COMMON ssri side effects
n/v
headache
sleep changes
increased anxiety/agitation or sedation
sexual dysfunction
SERIOUS ssri side effects
hyponatremia
increased bleeding/bruising
serotonin syndrome
most ACTIVATING ssri
fluoxetine
most SEDATING ssri
paroxetine
what is the “dirty ssri” and why
paroxetine: it is anticholinergic and antihistaminic, more sexual dysfunction, most weight gain
which ssri causes the most diarrhea and why
sertraline: it can affect serotonin in the gut
which ssris have most QT prolongation risk
citalopram
escitalopram
SNRI mechanism
inhibits the reuptake of serotonin and norepinephrine presynaptically
SNRI place in therapy
first/second line for MDD: low toxicity, addition mechanism with NE
what are the SNRIs
venlafaxine
duloxetine
desvenlafaxine
levomilnacipran
what are common side effects of SNRIs
same as SSRIs PLUS dose-dependent BP elevation, constipation
what are serious side effects of SNRIs
hyponatremia, increased bleeding/bruising, serotonin syndrome
SARIs
trazodone, nefazodone
SARI mechanism
5HT2A and 5HT2C receptor antagonist (post-synaptic)
inhibits serotonin reuptake
SARI place in therapy
not usually first or second line because too sedating
SARI adverse effects
sedation, dizziness, orthostatic hypotension, priapism
trazodone is used for
most commonly for insomnia rather than MDD
nefazodone boxed warning
liver failure
not first line due to this toxicity
NDRI mechanism
inhibits reuptake of norepi and dopamine, no serotonin activity
NDRI place in therapy
first or second line treatment of MDD
NDRI drug
bupropion
NDRI side effects
activation (insomnia, agitation, tremor), weight loss, headache, n/v, constipation